Stock APYX APYX MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Apyx Medical Corporation

Equities

APYX

US03837C1062

Delayed Nasdaq
Other stock markets
 11:52:42 2024-06-13 am EDT 		5-day change 1st Jan Change
1.46 USD -5.81% Intraday chart for Apyx Medical Corporation -8.75% -44.27%
May. 09 Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024
May. 09 Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q1 Revenue $10.2M
MT
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Apyx Medical Corporation Reaffirms Earnings Guidance for the Full Year Ending December 31, 2024
CI
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024
CI
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Investors -2-
DJ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
CI
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue
MT
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q3 Revenue $12M, vs. Street Est of $15.4M
MT
Apyx Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Apyx Medical Corporation Revises Earnings Guidance for the Year 2023
CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q2 Revenue $13.6M, vs. Street Est of $14.3M
MT
Apyx Medical Corporation Reaffirms Financial Guidance for the Year Ending December 31, 2023
CI
Apyx Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece
CI
Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2023
CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q1 Revenue $12.1M, vs. Street Est of $10.8M
MT
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APYX Stock
  4. News Apyx Medical Corporation
  5. Highlights